Between-trial heterogeneity in ARDS research
Por um escritor misterioso
Descrição
Identification of early and intermediate biomarkers for ARDS mortality by multi-omic approaches
Frontiers Validation of Messenger Ribonucleic Acid Markers Differentiating Among Human Acute Respiratory Distress Syndrome Subgroups in an Ovine Model of Acute Respiratory Distress Syndrome Phenotypes
Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling - ScienceDirect
Physiological and clinical variables identify ARDS classes and therapeutic heterogeneity to glucocorticoids: a retrospective study, BMC Pulmonary Medicine
Between-trial heterogeneity in ARDS research
COVID, Free Full-Text
Comparison of adult acute respiratory distress syndrome (ARDS)
Overview of the analysis plan and study design. ALVEOLI = Assessment of
Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling - eBioMedicine
Flow chart of study derivation and validation cohorts. ARDS, acute
Frontiers Unsuccessful and Successful Clinical Trials in Acute Respiratory Distress Syndrome: Addressing Physiology-Based Gaps
Designing an ARDS trial for 2020 and beyond: focus on enrichment strategies
ARDS plus pulmonary hypertension raises odds for mortality, longer hospital stay
Precision medicine in acute respiratory distress syndrome: workshop report and recommendations for future research
de
por adulto (o preço varia de acordo com o tamanho do grupo)
